Skip to main content
Premium Trial:

Request an Annual Quote

Signet Laboratories, Apolipoprotein J, GE Healthcare, Waters, LICOR


Signet Laboratories announced last week the availability of an antibody to Apolipoprotein J, a protein implicated in neurological disorders such as Alzheimer’s Disease, Down’s syndrome, and transmissible spongiform encephalopathies, among others.

“Reserach has demonstrated that Apo-J is involved in the process of beta amyloid aggregation in vitro and in vivo, but the method by which the aggregation is affected has remained largely elusive,” said Joe Bertelsen, Neuroscience Product Manager for Signet. “Signets’ new Apo-J, in addition to Signet’s existing panel of neuroscience antibodies, gives researchers a powerful tool.”

In addition to its function in neurological disorders, Apo-J is also implicated in prostate cancer, pancreatic cancer, large cell lymphoma and diabetes.

GE Healthcare has introduced its AKTAxpress TWIN, the second in a series of protein-purification systems to deliver fully-automated, multi-step purification of His- and GST-tagged proteins. The product is a smaller version of GE Healthcare’s AKTAxpress, which is a high-throughput protein purification system.

Waters announced this week the introduction of its Empower Chromatography Software to provide support for its Agilent 1100 Series Photodiode Array Detector. The software is designed to allow scientists to confidently identify sample components and verify spectral homogeneity by using sophisticated algorithms for peak purity and library matching, the company said.

LICOR announced this week the introduction of its new Aerius Automated Infrared Imaging System designed for protein discovery using infrared plate-based assays. The Aerius builds upon LI-COR's Odyssey two-channel infrared detection system by adding a fast microplate reader capable of handling up to 30 microplates in a single run.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.